United States Veterinary Therapeutics Market Report 2018

April 2018 | 101 pages | ID: UC634A0080EEN
QYResearch

Abstracts

In this report, the United States Veterinary Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Veterinary Therapeutics in these regions, from 2013 to 2025 (forecast).

United States Veterinary Therapeutics market competition by top manufacturers/players, with Veterinary Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Eli Lilly and Company (Elanco Animal Health)
• Merck Animal Health
• Sanofi (Merial Animal Health)
• Virbac
• Vetoquinol S.A.
• Zoetis, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Drugs
• Anti-inflammatory
• Parasiticides
• Other
• By Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• By Medicated Feed Additives
• Amino Acids
• Antibiotics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Veterinary Clinics
• Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Veterinary Therapeutics Market Report 2018

1 VETERINARY THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Veterinary Therapeutics
1.2 Classification of Veterinary Therapeutics by Product Category
  1.2.1 United States Veterinary Therapeutics Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Veterinary Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Anti-inflammatory
  1.2.4 Parasiticides
  1.2.5 Other
1.3 United States Veterinary Therapeutics Market by Application/End Users
  1.3.1 United States Veterinary Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Veterinary Clinics
  1.3.4 Drug Stores
1.4 United States Veterinary Therapeutics Market by Region
  1.4.1 United States Veterinary Therapeutics Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Veterinary Therapeutics Status and Prospect (2013-2025)
  1.4.3 Southwest Veterinary Therapeutics Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Veterinary Therapeutics Status and Prospect (2013-2025)
  1.4.5 New England Veterinary Therapeutics Status and Prospect (2013-2025)
  1.4.6 The South Veterinary Therapeutics Status and Prospect (2013-2025)
  1.4.7 The Midwest Veterinary Therapeutics Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Veterinary Therapeutics (2013-2025)
  1.5.1 United States Veterinary Therapeutics Sales and Growth Rate (2013-2025)
  1.5.2 United States Veterinary Therapeutics Revenue and Growth Rate (2013-2025)

2 UNITED STATES VETERINARY THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Veterinary Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Veterinary Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Veterinary Therapeutics Average Price by Players/Suppliers (2013-2018)
2.4 United States Veterinary Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Veterinary Therapeutics Market Concentration Rate
  2.4.2 United States Veterinary Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Veterinary Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VETERINARY THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Veterinary Therapeutics Sales and Market Share by Region (2013-2018)
3.2 United States Veterinary Therapeutics Revenue and Market Share by Region (2013-2018)
3.3 United States Veterinary Therapeutics Price by Region (2013-2018)

4 UNITED STATES VETERINARY THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Veterinary Therapeutics Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Veterinary Therapeutics Revenue and Market Share by Type (2013-2018)
4.3 United States Veterinary Therapeutics Price by Type (2013-2018)
4.4 United States Veterinary Therapeutics Sales Growth Rate by Type (2013-2018)

5 UNITED STATES VETERINARY THERAPEUTICS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Veterinary Therapeutics Sales and Market Share by Application (2013-2018)
5.2 United States Veterinary Therapeutics Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES VETERINARY THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Veterinary Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer AG Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim GmbH
  6.2.2 Veterinary Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Ceva Sante Animale
  6.3.2 Veterinary Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ceva Sante Animale Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Dechra Pharmaceuticals PLC
  6.4.2 Veterinary Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly and Company (Elanco Animal Health)
  6.5.2 Veterinary Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Merck Animal Health
  6.6.2 Veterinary Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck Animal Health Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Sanofi (Merial Animal Health)
  6.7.2 Veterinary Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Virbac
  6.8.2 Veterinary Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Virbac Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Vetoquinol S.A.
  6.9.2 Veterinary Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Vetoquinol S.A. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Zoetis, Inc.
  6.10.2 Veterinary Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Zoetis, Inc. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 VETERINARY THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Veterinary Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Veterinary Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Veterinary Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Veterinary Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Veterinary Therapeutics Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Veterinary Therapeutics Sales Volume Forecast by Type (2018-2025)
11.3 United States Veterinary Therapeutics Sales Volume Forecast by Application (2018-2025)
11.4 United States Veterinary Therapeutics Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Veterinary Therapeutics
Figure United States Veterinary Therapeutics Market Size (K Units) by Type (2013-2025)
Figure United States Veterinary Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Anti-inflammatory Product Picture
Figure Parasiticides Product Picture
Figure Other Product Picture
Figure United States Veterinary Therapeutics Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Veterinary Therapeutics by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Veterinary Clinics Examples
Table Key Downstream Customer in Veterinary Clinics
Figure Drug Stores Examples
Table Key Downstream Customer in Drug Stores
Figure United States Veterinary Therapeutics Market Size (Million USD) by Region (2013-2025)
Figure The West Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Veterinary Therapeutics Sales (K Units) and Growth Rate (2013-2025)
Figure United States Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Veterinary Therapeutics Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Veterinary Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Veterinary Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Veterinary Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Veterinary Therapeutics Sales Share by Players/Suppliers
Figure United States Veterinary Therapeutics Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Veterinary Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Veterinary Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Veterinary Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Veterinary Therapeutics Revenue Share by Players/Suppliers
Table United States Market Veterinary Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Veterinary Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Veterinary Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Veterinary Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Veterinary Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Veterinary Therapeutics Product Category
Table United States Veterinary Therapeutics Sales (K Units) by Region (2013-2018)
Table United States Veterinary Therapeutics Sales Share by Region (2013-2018)
Figure United States Veterinary Therapeutics Sales Share by Region (2013-2018)
Figure United States Veterinary Therapeutics Sales Market Share by Region in 2017
Table United States Veterinary Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Veterinary Therapeutics Revenue Share by Region (2013-2018)
Figure United States Veterinary Therapeutics Revenue Market Share by Region (2013-2018)
Figure United States Veterinary Therapeutics Revenue Market Share by Region in 2017
Table United States Veterinary Therapeutics Price (USD/Unit) by Region (2013-2018)
Table United States Veterinary Therapeutics Sales (K Units) by Type (2013-2018)
Table United States Veterinary Therapeutics Sales Share by Type (2013-2018)
Figure United States Veterinary Therapeutics Sales Share by Type (2013-2018)
Figure United States Veterinary Therapeutics Sales Market Share by Type in 2017
Table United States Veterinary Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Veterinary Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Veterinary Therapeutics by Type (2013-2018)
Figure Revenue Market Share of Veterinary Therapeutics by Type in 2017
Table United States Veterinary Therapeutics Price (USD/Unit) by Types (2013-2018)
Figure United States Veterinary Therapeutics Sales Growth Rate by Type (2013-2018)
Table United States Veterinary Therapeutics Sales (K Units) by Application (2013-2018)
Table United States Veterinary Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Veterinary Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Veterinary Therapeutics Sales Market Share by Application in 2017
Table United States Veterinary Therapeutics Sales Growth Rate by Application (2013-2018)
Figure United States Veterinary Therapeutics Sales Growth Rate by Application (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Bayer AG Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Bayer AG Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Ceva Sante Animale Basic Information List
Table Ceva Sante Animale Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ceva Sante Animale Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Ceva Sante Animale Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Ceva Sante Animale Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Dechra Pharmaceuticals PLC Basic Information List
Table Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company (Elanco Animal Health) Basic Information List
Table Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Merck Animal Health Basic Information List
Table Merck Animal Health Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Animal Health Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Merck Animal Health Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Merck Animal Health Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Sanofi (Merial Animal Health) Basic Information List
Table Sanofi (Merial Animal Health) Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi (Merial Animal Health) Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Sanofi (Merial Animal Health) Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Virbac Basic Information List
Table Virbac Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Virbac Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Virbac Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Virbac Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Vetoquinol S.A. Basic Information List
Table Vetoquinol S.A. Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Vetoquinol S.A. Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Vetoquinol S.A. Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Vetoquinol S.A. Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Zoetis, Inc. Basic Information List
Table Zoetis, Inc. Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Zoetis, Inc. Veterinary Therapeutics Sales Growth Rate (2013-2018)
Figure Zoetis, Inc. Veterinary Therapeutics Sales Market Share in United States (2013-2018)
Figure Zoetis, Inc. Veterinary Therapeutics Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Veterinary Therapeutics
Figure Manufacturing Process Analysis of Veterinary Therapeutics
Figure Veterinary Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Veterinary Therapeutics Major Players/Suppliers in 2017
Table Major Buyers of Veterinary Therapeutics
Table Distributors/Traders List
Figure United States Veterinary Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Veterinary Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Veterinary Therapeutics Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Type in 2025
Table United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Application in 2025
Table United States Veterinary Therapeutics Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Veterinary Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Veterinary Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Veterinary Therapeutics Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources